At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- FinancialsAltman Z-Score 2.17: grey zone
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.37%Below 5Y avg (0.41%)
Annual Rate
INR 0.80Paid semi-annual
Payout Ratio
172.8%High
Last Ex-Dividend
Sep 4, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
26.72BINR303.36M · vs all stocks (USD)
Revenue (TTM)
18.51BINR178.45M · vs all stocks (USD)
Profit Margin
-0.27%Beta
0.5340xvs all stocks
52-Week Change
-5.37%vs all stocks
Forward Annual Dividend Yield
0.37%vs all stocks
Market Capitalization
26.72BINR303.36M · vs all stocks (USD)
Enterprise Value
33.87BINR317.20M · vs all stocks (USD)
Forward P/E
24.83xPrice to Sales (TTM)
1.49xPrice to Book (MRQ)
2.36xEnterprise to Revenue
1.83xEnterprise to EBITDA
12.61xGross Margin
54.33%Profit Margin
-0.27%Operating Margin
5.54%Return on Assets (TTM)
2.73%Return on Equity (TTM)
-0.42%Revenue (TTM)
18.51BINR178.45M · vs all stocks (USD)
Revenue per Share (TTM)
149.72INRUpdated Nov 17, 2026Quarterly Revenue Growth
36.30%Gross Profit (TTM)
9.39BINR91.22M · vs all stocks (USD)
EBITDA (TTM)
2.45BINR24.44M · vs all stocks (USD)
Net Income (TTM)
-50.00MINR1.06M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
7.68%Operating Cash Flow (TTM)
2.76BINR32.02M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
242.25MINR12.74M · vs all stocks (USD)
Forward Annual Dividend Rate
0.8000INRUpdated Nov 17, 2026Forward Annual Dividend Yield
0.37%vs all stocks
Trailing Annual Dividend Rate
0.6000INRUpdated Nov 17, 2026Trailing Annual Dividend Yield
0.28%vs all stocks
5-Year Average Dividend Yield
0.41%vs all stocks
Payout Ratio
172.84%Revenue
16.95BINRFY2026 · Mar 31, 2026Cost of Goods Sold
7.62BINRFY2026 · Mar 31, 2026Gross Profit
9.34BINRFY2026 · Mar 31, 2026Operating Income
566.00MINR5.94M · vs all stocks (USD)
Pre-tax Income
-783.00MINRFY2026 · Mar 31, 2026Income Tax Expense
-295.00MINRFY2026 · Mar 31, 2026Net Income
-488.00MINRFY2026 · Mar 31, 2026EBIT
-162.00MINRFY2026 · Mar 31, 2026EBITDA (Income Statement)
2.33BINRFY2026 · Mar 31, 2026Other Operating Expenses
4.60BINRFY2026 · Mar 31, 2026Non-operating Interest Expense
621.00MINRFY2026 · Mar 31, 2026Preferred Stock Dividends
0.00INRFY2026 · Mar 31, 2026Operating Cash Flow
1.34BINRFY2026 · Mar 31, 2026Free Cash Flow
-139.00MINRFY2026 · Mar 31, 2026Cash & Cash Equivalents (End of Period)
96.00MINRFY2026 · Mar 31, 2026Starting Profit (CF Statement)
-783.00MINRFY2026 · Mar 31, 2026Other Non-cash Items
1.08BINRFY2026 · Mar 31, 2026Change in Accounts Receivable (CF)
1.32BINRFY2026 · Mar 31, 2026Change in Other Assets/Liabilities
-282.00MINRFY2026 · Mar 31, 2026Capital Expenditures
-1.48BINRFY2026 · Mar 31, 2026Purchase of Investments
0.00INRFY2026 · Mar 31, 2026Sale of Investments
4.00MINRFY2026 · Mar 31, 2026Other Investing Activity
12.00MINRFY2026 · Mar 31, 2026Net Investing Cash Flow
-1.46BINRFY2026 · Mar 31, 2026Long-term Debt Issuance
1.35BINRFY2026 · Mar 31, 2026Long-term Debt Payments
-1.31BINRFY2026 · Mar 31, 2026Net Short-term Debt Issuance
-848.00MINRFY2026 · Mar 31, 2026Common Dividends Paid
-123.00MINRFY2026 · Mar 31, 2026Net Financing Cash Flow
-936.00MINRFY2026 · Mar 31, 2026Shares Outstanding
123.30MSharesUpdated Nov 17, 2026Float Shares
38.45MSharesUpdated Nov 17, 2026% Held by Insiders
69.10%vs all stocks
% Held by Institutions
6.20%vs all stocks
Total Cash (MRQ)
228.00MINR2.03M · vs all stocks (USD)
Total Cash per Share (MRQ)
1.83INRUpdated Nov 17, 2026Total Debt (MRQ)
6.39BINR71.77M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.5407xCurrent Ratio (MRQ)
1.18xBook Value per Share (MRQ)
94.90INRUpdated Nov 17, 2026Total Assets
23.65BINR248.44M · vs all stocks (USD)
Total Current Assets
8.84BINRFY2026 · Mar 31, 2026Total Liabilities
11.67BINRFY2026 · Mar 31, 2026Total Non-current Assets
14.81BINRFY2026 · Mar 31, 2026Total Non-current Liabilities
4.88BINRFY2026 · Mar 31, 2026Total Current Liabilities
6.79BINRFY2026 · Mar 31, 2026Cash & Cash Equivalents
96.00MINRFY2026 · Mar 31, 2026Other Short-term Investments
360.00MINRFY2026 · Mar 31, 2026Accounts Receivable
4.42BINRFY2026 · Mar 31, 2026Inventory
3.58BINRFY2026 · Mar 31, 2026Accounts Payable
2.67BINRFY2026 · Mar 31, 2026Short-term Debt
3.08BINRFY2026 · Mar 31, 2026Other Current Liabilities
199.00MINRFY2026 · Mar 31, 2026Long-term Debt
3.76BINRFY2026 · Mar 31, 2026Other Non-current Liabilities
519.00MINRFY2026 · Mar 31, 2026Common Stock (Book)
247.00MINRFY2026 · Mar 31, 2026Total Shareholders' Equity
11.99BINR125.91M · vs all stocks (USD)
52-Week Low
145.95INRUpdated Nov 17, 202652-Week High
260.80INRUpdated Nov 17, 202652-Week Change
-5.37%vs all stocks
Beta
0.5340xvs all stocks
50-Day MA
218.93INRUpdated Nov 17, 2026200-Day MA
204.50INRUpdated Nov 17, 2026Avg 10-Day Volume
37.86KSharesUpdated Nov 17, 2026Avg 30-Day Volume
31.07KSharesUpdated Nov 17, 2026Diluted EPS (TTM)
-0.4000INRUpdated Nov 17, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.58Profit Margin: 0.01
Financial Health
Altman Z-Score 2.17: grey zoneSignificant
Altman Z-Score: 2.17
High earnings qualityNotable
Earnings Quality Score: 0.77
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Shin Poong Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Essex Bio-Technology Ltd.
Tier 1ProductionApproval-Gated PipelineRule
JBM
Tier 1ProductionApproval-Gated PipelineRuleFlow
Animalcare Group Plc
Tier 1ProductionApproval-Gated PipelineRuleFlow
Contineum Therapeutics, Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Dirui Industrial Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Eikon Therapeutics, Inc.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Benitec Biopharma Inc.
Tier 1ProductionApproval-Gated PipelineRule
Canopy Growth Corporation
Tier 1ProductionApproval-Gated PipelineFlowRule
Zhejiang Zhenyuan Co., Ltd.
Tier 1ProductionApproval-Gated PipelineFlowRule